A Quiet Period for Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2007.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c83505) has announced the addition of new Decision Resources report Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2007 to their offering. Introduction The fourth quarter of 2007 was fairly quiet in the pricing and reimbursement arena. In the United States, the presidential election, legislation in California, and a new initiative from health plans focused attention on the uninsured and universal coverage. A public consultation on the future of pharmaceuticals highlighted the challenges confronting drug manufacturers in Europe, while the Japanese government seemingly changed course on overhauling its pharmaceutical pricing and reimbursement system. Get the Answers You Need to Shape Your Strategy - Pending U.S. legislation would allow the Department of Health and Human Services Noun 1. Department of Health and Human Services - the United States federal department that administers all federal programs dealing with health and welfare; created in 1979 Health and Human Services, HHS to create a national Medicare formulary formulary /for·mu·lary/ (for´mu-lar?e) a collection of recipes, formulas, and prescriptions. National Formulary see under N. for·mu·lar·y n. . How would HHS HHS Department of Health and Human Services. use this formulary in its price negotiations with pharmaceutical manufacturers? - U.S. employers and health plans are recognizing the financial and health benefits of promoting greater use of generic drugs and improved adherence to chronic disease therapy. What strategies are they pursuing in their efforts to improve patient adherence with chronic disease therapy and encourage the use of generics? - Pressure to tackle the growth in the ranks of uninsured U.S. residents is mounting. Which states have enacted their own universal coverage legislation? How will the presidential election affect this issue at the national level? Scope - Overview: major events in the fourth quarter of 2007 in the pricing, reimbursement, and prescribing environment in the major pharmaceutical markets under study. - United States: leading stories in 2007, including SCHIP SCHIP State Children's Health Insurance Program , decline in drug imports, copayment co·pay·ment n. A fixed fee that subscribers to a medical plan must pay for their use of specific medical services covered by the plan. copayment, n reductions and waivers for generics and chronic disease therapies, and many others. - European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community : responses to public consultation on the future of pharmaceuticals in Europe. - France: pressures on pharmaceutical industry, potential reforms for chronic disease treatments. - Germany: new reference pricing groups, health economic evaluation, growth in rebate contracts. - Italy: market trends in 2007. - Spain: amendments to the reference pricing system. - United Kingdom: proposed amendments to NICE's methods for technology appraisals, OFT report on direct-to-pharmacy distribution, abolition of prescription charges in Scotland. - Japan: delay in overhaul of pricing and reimbursement system, efforts to increase use of generics. - Outlook and implications for the pharmaceutical industry: the outlook for pharma in the United States, Europe, and Japan. Topics Include: Executive Summary Strategic Considerations Stakeholder Implications Overview United States Temporary Measures to Defer Medicare Reimbursement Cuts and Prolong Basic Health Insurance for Children Decline in Drug Imports Pressure for the Introduction of a Medicare Formulary PBMs Commit to Greater Transparency Call for Infl ation-Based Medicaid Rebates Copayment Reductions and Waivers for Generics and Chronic Disease Therapies Momentum for Universal Health Insurance Benefit Cuts at Age 65 Judged Acceptable European Union Responses to Public Consultation on the Future of Pharmaceuticals in Europe France French Health Care System at a Crossroads Social Security Budget Increases Pressure on Pharmaceutical Industry Potential Reform of Coverage of Treatments for Chronic Diseases Germany Market Trends in 2007 Pharmaceutical Budget for 2008 Introduction of New Reference Pricing Groups Continuing Debate Over Procedures for Health Economic Evaluation Continued Growth in Rebate Contracts Italy Market Trends Spain Amendments to the Reference Pricing System United Kingdom Proposed Amendments to NICE's Methods for Technology Appraisals OFT Report on Direct-to-Pharmacy Distribution Abolition of Prescription Charges in Scotland Japan Overhaul of Pricing and Reimbursement System Unlikely in 2008 Change to Prescription Form to Stimulate Generics Substitution Outlook and Implications for the Pharmaceutical Industry List of Tables List of Figures Companies Mentioned: - AARP AARP, a nonprofit, nonpartisan national organization dedicated to "enriching the experience of aging"; membership is open to people age 50 or older. Founded in 1958 by Ethel Percy Andrus as American Association of Retired Persons, AARP now has over 30 million - Aetna Pharmacy Management - Agency for Healthcare Research and Quality Agency for Healthcare Research and Quality, n.pr formerly known as the Agency for Health Care Policy and Research, this agency researches the quality of medical care and health services. - Agenzia Italiana del Farmaco (AIFA AIFA Agenzia italiana del Farmaco (Rome, Italy) AIFA Accredited Investment Fiduciary Analyst AIFA Association of Independent Financial Advisers AIFA Accredited Investment Fiduciary Auditor AIFA American International Freight Association ; Italian Medicines Agency) - Allgemeine Ortskrankenkassen (AOK AOK Allgemeine Ortskrankenkasse AOK Age of Kings (Microsoft game) AOK Association of Knowledgework AOK Karpathos, Greece - Karpathos (Airport Code) AOK All Is Okay ; General Local Health Insurance Funds) - America's Health Insurance Plans - Arzneimittelkommission der Deutschen Arzteschaft (Pharmaceutical Commission of the German Medical Profession) - Berlin-Chemie - BlueCross and Blue Shield Blue Shield A US not-for-profit health care insurer that is a reimbursement intermediary for physicians. Cf Blue Cross. of Alabama - Blue Shield of California Blue Shield of California is a not-for-profit health insurance provider headquartered in San Francisco, California. An independent licensee of the Blue Cross and Blue Shield Association, Blue Shield of California is an incorporated, wholly owned subsidiary of California Physicians' - Boehringer Ingelheim - Bundesverband der Betriebskrankenkassen (Federal Association of Occupational Health Insurance Funds) - Bundesvereinigung Deutscher Apothekerverbande (Federal Union of German Pharmacists Associations) - Catalyst Rx - Centers for Medicare and Medicaid Services The Centers for Medicare and Medicaid Services (CMS), previously known as the Health Care Financing Administration (HCFA), is a federal agency within the United States Department of Health and Human Services (DHHS) that administers the Medicare program and - Chuikyo (Central Social Insurance Medical Council) - CIGNA CIGNA CG (Connecticut General Life Insurance Company) INA (Insurance Company of North America) Pharmacy Management - Consumers Union - CVS (1) (Concurrent Versions System) A version control system for Unix that was initially developed as a series of shell scripts in the mid-1980s. CVS maintains the changes between one source code version and another and stores all the changes in one file. Caremark - Department of Health and Human Services (United States) - Equal Employment Opportunity Commission - European Federation of Pharmaceutical Industries and Associations The European Federation of Pharmaceutical Industries and Associations or EFPIA is the organization representing the research-based pharmaceutical industry operating in Europe. - EuroQol - Express Scripts - Federazione Nazionale dei Titolari di Farmacia Italiani (Federfarma; National Federation of Italian Pharmacy Owners) - Gemeinsamer Bundesausschuss der Arzte, Zahnarzte, Krankenhauser und Krankenkassen (Joint Federal Committee of Physicians, Dentists, Hospitals, and Health Insurance Funds) - GlaxoSmithKline - Haute Autorite de Sante (National Health Authority) - HR Policy Association's Pharmaceutical Purchasing Coalition - Humana Pharmacy - IMS Health - Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen (Institute for Quality and Efficiency in Health Care) - Kassenarztliche Bundesvereinigung (Federal Union of Health Insurance Fund Physicians) - Medco Health Solutions Medco Health Solutions, Inc. (NYSE: MHS) is a leading pharmacy benefit manager (PBM) company based in Franklin Lakes, New Jersey. The current chairman is David Snow. The company formed in August 2003 as a spinoff from Merck & Co.. - Medicare Rights Center - Ministry of Heath, Labor, and Welfare - National Health Service - National Institute for Health and Clinical Excellence “NICE” redirects here. For other uses, see NICE (disambiguation). The National Institute for Health and Clinical Excellence or NICE is a Special Health Authority of the National Health Service in England and Wales. - Pfi zer - Prime Therapeutics - Restat - Servizio Sanitario Nazionale (National Health Service) - Spitzenverbande der Krankenkassen (leading associations of the health insurance funds) - SXC Health Solutions - U.S. Census Bureau - Walgreens Health Initiatives - WellPoint NextRx For more information visit http://www.researchandmarkets.com/reports/c83505 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion